Having trouble accessing articles? Reset your cache.

BMN 195: Development discontinued

BioMarin discontinued development of BMN 195 after a double-blind, placebo-controlled, single and multiple dose-escalation Phase I trial in

Read the full 183 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE